|
90Y-NM600 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: alkylphosphocholine (APCh) analog
Madison, Wisconsin1 trial
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
UW Carbone Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.